Retatrutide is an investigational compound that is not FDA-approved, and PlexusDx does not sell, distribute, or prescribe retatrutide or any other investigational peptide in this category
Retatrutide improves insulin sensitivity through GLP-1 and GIP pathways, while growth hormone can transiently increase insulin resistance
CrossRef Phellinus igniarius Polysaccharides Ameliorate Nonalcoholic Fatty Liver Disease Through Suppressing SREBP1 YingJun Zhang, KaiYue He, WeiTao Yin, QingChun Zhao, XiongYan Xiang, JunQi Li, ZhiFeng Zhang, YongPing Jian, ZhiXiang Xu Food Frontiers .2026;[Epub] CrossRef Development and validation of an explainable machine learning model using routine laboratory biomarkers for identifying prevalent MASLD: Evidence from two observational studies Jialin Wu, Wenting Wei, Terry Cheuk-Fung Yip, Xinyi Deng, Bonan Chen, Yang Lyu, Peiyao Yu, Tiejun Feng, Fuda Xie, Ge Zhang, Kangmin Zhuang, Aimin Li, Wei Kang Clinical and Experimental Medicine .2026;[Epub] CrossRef Weight loss and alcohol reduction synergize for hepatic steatosis remission in elderly patients with metabolic alcohol-associated liver disease (MetALD): a retrospective cohort study Tianxiang Lin, Xiaoxue Yuan, Yanrong Zhao, Wei Wang, Chen Wu, Song Yang, Yinwei Qiu International Journal of Obesity .2026;[Epub] CrossRef Hepatic and Cardiovascular Outcomes in Primary Biliary Cholangitis With MetabolicDysfunction Associated Steatotic Liver Disease Jarell JieRae Tan, Joo Wei Ethan Quek, Sean Shao Wei Lam, MingHua Zheng, Christophe Corpechot, Aldo J
This is where the situation becomes difficult for a U.S
4 GI AEs associated with GIPR modulation Because the food aversive and avoidant effects of GLP-1R agonism appear to be dissociable from satiety, it is theoretically possible to leverage this finding in a next generation, tailored pharmacology
Limited Availability: Drug shortages are a recurring issue, leaving many patients unable to access their prescriptions
